Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Endologix Announces Favorable Markman Ruling in Cook Patent Litigation

August 17, 2011 9:48 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 17, 2011 /- Endologix, Inc. (Nasdaq: ELGX ), developer and marketer of minimally invasive treatments for aortic disorders, announced today that Judge Tanya Walton Pratt of the United States District Court for the Southern District of Indiana in Indianapolis has issued...

Stryker Orthopaedics Enters into Agreement with OrthoSensor for Intelligent Surgical Platform

August 17, 2011 9:48 am | by Bio-Medicine.Org | News | Comments

MAHWAH, N.J. and SUNRISE, Fla., Aug. 17, 2011 /- Stryker Corporation's Orthopaedics Division and OrthoSensor, Inc., the leader in intelligent orthopaedics, today announced an agreement in which OrthoSensor will provide the OrthoSensor™ Knee Trial, designed for use with Stryker's...

SuccessEHS Clients Experience 11 Percent Increase in Visits

August 17, 2011 9:47 am | by Bio-Medicine.Org | News | Comments

BIRMINGHAM, Ala., Aug. 17, 2011 /- SuccessEHS announced the results of its Comprehensive Client Performance Analysis, which revealed that SuccessEHS clients experience an average volume increase of 11 percent per physician in the first six months after going live on the SuccessEHS...

Advertisement

Former PhRMA President Billy Tauzin Joins Leading 340B Drug Administrator

August 17, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

SAN ANTONIO, Aug. 17, 2011 /PRNewswire-USNewswire/ -- Former Congressman and PhRMA CEO Billy Tauzin has joined the board of the pharmaceutical benefits management company CaptureRx . He will also serve as the company's Chief Industry Relations Officer. Tauzin will work on behalf of...

The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face

August 17, 2011 9:43 am | by Bio-Medicine.Org | News | Comments

ATLANTA, Aug. 17, 2011 /- The 14th annual Victory Over Diabetes event, hosted by the American Diabetes Association (the Association), will take place in Atlanta on August 20, featuring educational workshops, free health screenings and resources designed to encourage African Americans to...

Polymedco Announces Publication in Epidemiologic Reviews

August 17, 2011 9:42 am | by Bio-Medicine.Org | News | Comments

CORTLANDT MANOR, N.Y., Aug. 17, 2011 /- Polymedco is pleased to announce a publication in Epidemiologic Review, "Organized Colorectal Cancer Screening in Integrated Health Care Systems" by Theodore R Levin, Laura Jamieson, Daniel A Burley, Juan Reyes, Michael Oehrli, and Cindy Caldwell...

AHRA 2011: Malpractice Suits Down, but Potential Liability Lingers

August 17, 2011 6:36 am | by Diagnostic Imaging | News | Comments

GRAPEVINE, TEXAS - Facing a medical malpractice lawsuit can be a daunting, years-long process. But Detroit lawyer David M. Ottenwess had some simple, initial advice for radiology managers: Don't panic.

AHRA 2011: Industry Slow to Colombini MRI Lessons?

August 17, 2011 6:35 am | by Diagnostic Imaging | News | Comments

GRAPEVINE, TEXAS - A decade after a 6-year-old boy died in a freak MRI accident, what have medical regulators done to ensure greater MRI safety?

Advertisement

New York Dermatologist Offers the Latest in Pelleve Wrinkle Reduction Technology

August 17, 2011 3:44 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 17, 2011 /- Leading dermatologist Dr. Arielle Kauvar announces that her practice, New York Laser & Skin Care , now offers the newest generation of the Pelleve ™ Wrinkle Reduction System with the new GlideSafe™ Handpieces. The Pelleve System from Ellman...

Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics

August 17, 2011 3:44 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 17, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Needle-Free Drug Delivery: The Market for Alternatives to Needle-Based Systems for Vaccine and Biologics...

GCC Paediatric Summit, Bringing Together the Very Best in Children's Healthcare

August 17, 2011 3:43 am | by Bio-Medicine.Org | News | Comments

DUBAI, August 17, 2011 /- In recent years The Gulf countries have seen great improvements in healthcare infrastructure and services thanks to a very strong and growing economy. However, the region is suffering from an increased sedentary lifestyle, resulting in a dramatic rise of chronic...

Levosimendan - Comprehensive Patent Search

August 17, 2011 3:43 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 17, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Levosimendan - Comprehensive patent search...

Kuros Completes Patient Recruitment in its European Clinical Study With KUR-023, its Novel Dural Sealant Product Candidate

August 16, 2011 10:46 pm | by Bio-Medicine.Org | News | Comments

ZURICH, August 17, 2011 /- Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has completed patient recruitment in a clinical trial...

Advertisement

NADDI and the C.A.R.E.S. Alliance Join Attorney General Bondi in Fight Against Prescription Drug Abuse

August 16, 2011 9:44 am | by Bio-Medicine.Org | News | Comments

TALLAHASSEE, Fla., Aug. 16, 2011 /PRNewswire-USNewswire/ -- The National Association of Drug Diversion Investigators (NADDI) and the C.A.R.E.S. (Collaborating and Acting Responsibly to Ensure Safety) Alliance (SM) have joined Attorney General Pam Bondi in addressing a serious public...

HealthWarehouse.com Reports 43% Revenue Growth Year-Over-Year

August 16, 2011 9:44 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, Aug. 16, 2011 /- HealthWarehouse.com, Inc. (OTC: HEWA) a leading VIPPS accredited retail mail-order pharmacy, today announced its financial results for the quarter ended June 30, 2011. For the quarter ended June 30, 2011, the Company's net sales increased $753,059 to...

Seattle Children's Invention Lands Major Funding with Hopes of Saving Thousands of Infant Lives Globally Each Year

August 16, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

SEATTLE, Aug. 16, 2011 /PRNewswire-USNewswire/ -- Seattle Children's Research Institute today announced the receipt of a two-year, $2.3 million grant from the Bill & Melinda Gates Foundation to complete prototype development of its new respiratory support device, called Seattle...

Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis

August 16, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

SPARTANBURG, S.C., Aug. 16, 2011 /- Femasys Inc. and Norgenix Pharmaceuticals, LLC today announced an agreement for exclusive distribution rights in the United States as well as US territories and military bases for Femasys' FemVue™ Saline-Air Device. This FDA cleared device is used...

Childbearing May Increase Risk of Hormone Receptor-Negative Breast Cancer in African-American Women

August 16, 2011 9:40 am | by AACR | News | Comments

Tweet •    Two or more full-term births put African-American women at higher risk.•    Increased risk occurred only in women who did not breast-feed. PHILADELPHIA — African-American women are at higher risk for hormone receptor-negative...

Beacon Enterprise Solutions Announces $3.4 Million Contract Award With the Veteran's Administration

August 16, 2011 6:47 am | by Bio-Medicine.Org | News | Comments

LOUISVILLE, Ky., Aug. 16, 2011 /- Beacon Enterprise Solutions Group, Inc. (OTC BB: BEAC) ( www.askbeacon.com ), an emerging global leader in the design, implementation and management of high performance Information Technology Systems (ITS) infrastructure solutions, today announces the...

China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.'s Sales Forecast in Excess of $10,000,000

August 16, 2011 6:47 am | by Bio-Medicine.Org | News | Comments

WEST PALM BEACH, Fla., Aug. 16, 2011 /- China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that SurgLine, Inc. ("SurgLine") and one of its previously announced stocking distributors, OptiMedical Corp. ("OptiMedical") is in the final stages of completing a multi-million dollar...

Beth Israel Deaconess Medical Center Treats 2,000th Patient with the CyberKnife System

August 16, 2011 6:46 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Aug. 16, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), the premier radiation oncology company, announced today that the Beth Israel Deaconess Medical Center (BIDMC), a teaching hospital of Harvard Medical School and a leader in pioneering innovative technology to...

Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's Genousâ„¢ Stent in Patients at High Risk for Restenosis

August 16, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

HONG KONG, Aug. 16, 2011 /- OrbusNeich today announced that the that the company's Genous Stent showed no significant difference in the rate of target vessel failure (TVF) at two years compared to the Taxus Liberte™ paclitaxel-eluting stent in patients with de novo coronary artery...

CR Magazine Congratulates Cynthia Ryan, Ph.D., Clarion Award Recipient

August 16, 2011 6:40 am | by AACR | News | Comments

Tweet PHILADELPHIA — CR magazine, the AACR’s magazine for cancer survivors, their families and caregivers, congratulates contributing writer Cynthia Ryan, Ph.D., on her Clarion Award-winning article, “Homeless With Cancer,” which was published in CR’s Fall...

Draft Guidance for Industry and Food and Drug Administration Staff - Postmarket Surveillance Under Section 522 of the Federal Food, Drug and Cosmetic Act

August 16, 2011 5:31 am | by U.S. Food & Drug Administration | News | Comments

Postmarket surveillance under section 522 of the Federal Food, Drug, and Cosmetic Act (the act) is one means by which the FDA can obtain additional safety and/or effectiveness data for a device after it has been cleared through the premarket...

New Study Shows Modified Citrus Pectin Activates Powerful Immune Responses

August 16, 2011 2:43 am | by Bio-Medicine.Org | News | Comments

SANTA ROSA, Calif., Aug. 16, 2011 /- Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function. The study found that MCP activated B-cells in a dose-dependent manner, and induced a highly significant...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading